Oncosil Medical Call 6 AUD Oncosil Medical 20Dec2027 Opt
About OSLOC
OncoSil Medical (OSL) is a global medical device company focused on Interventional Oncology and focuses on improving the outcomes for people living with cancer by utilizing the selected and targeted intratumoural placement of Phosphorous-32 (32P) Microparticles in addition to chemotherapy.
Find out what a historical investment in Oncosil Medical Call 6 AUD Oncosil Medical 20Dec2027 Opt would be worth today using our OSLOC stock calculator.
Buying OSLOC shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Oncosil Medical Call 6 AUD Oncosil Medical 20Dec2027 Opt in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in OSLOC
What is the ticker symbol of Oncosil Medical Call 6 AUD Oncosil Medical 20Dec2027 Opt?
The ticker symbol for Oncosil Medical Call 6 AUD Oncosil Medical 20Dec2027 Opt is OSLOC.
How much is one share of OSLOC?
One share of OSLOC is valued at $0.04 as of 20 November 2026.
What is the market capitalisation of Oncosil Medical Call 6 AUD Oncosil Medical 20Dec2027 Opt OSLOC?
As of 20 November 2026 Oncosil Medical Call 6 AUD Oncosil Medical 20Dec2027 Opt has a market cap of $21.47M.
What is the P/E ratio of OSLOC?
The Price to Earnings ratio of OSLOC is -0.07.
What is the Earnings Per Share of OSLOC?
The Earnings Per Share of OSLOC is -$0.48.
What is the 52-week high for Oncosil Medical Call 6 AUD Oncosil Medical 20Dec2027 Opt stock?
The Oncosil Medical Call 6 AUD Oncosil Medical 20Dec2027 Opt 52-week high stock price is $0.06.
What is the 52-week low for Oncosil Medical Call 6 AUD Oncosil Medical 20Dec2027 Opt stock?
The Oncosil Medical Call 6 AUD Oncosil Medical 20Dec2027 Opt 52-week low stock price is $0.02.
Can I buy OSLOC shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy OSLOC shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.